Yüklüyor......

Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia

BACKGROUND: We report on the clinical and biochemical outcomes in a 20-year-old male suffering from active craniofacial monostotic fibrous dysplasia (MFD) of the left mandible treated with the RANK-L inhibitor, denosumab, following unsatisfactory responses to prior long-term bisphosphonates therapy....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cases Miner Bone Metab
Asıl Yazarlar: Eller-Vainicher, Cristina, Rossi, Diego Sergio, Guglielmi, Giuseppe, Beltramini, Giada Anna, Cairoli, Elisa, Russillo, Antonio, Mantovani, Giovanna, Spada, Anna, Chiodini, Iacopo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: CIC Edizioni Internazionali 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318184/
https://ncbi.nlm.nih.gov/pubmed/28228794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11138/ccmbm/2016.13.3.253
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!